The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals
- 28 February 2017
- journal article
- research article
- Published by Wiley in Hippocampus
- Vol. 27 (6), 653-667
- https://doi.org/10.1002/hipo.22721
Abstract
Alzheimer's disease is characterized by hippocampal atrophy. Other factors also influence the hippocampal volume, but their interactive effect has not been investigated before in cognitively healthy individuals. The aim of this study is to evaluate the interactive effect of key demographic and clinical factors on hippocampal volume, in contrast to previous studies frequently investigating these factors in a separate manner. Also, to investigate how comparable the control groups from ADNI, AIBL, and AddNeuroMed are with five population‐based cohorts. In this study, 1958 participants were included (100 AddNeuroMed, 226 ADNI, 155 AIBL, 59 BRC, 295 GENIC, 279 BioFiNDER, 398 PIVUS, and 446 SNAC‐K). ANOVA and random forest were used for testing between‐cohort differences in demographic‐clinical variables. Multiple regression was used to study the influence of demographic‐clinical variables on hippocampal volume. ANCOVA was used to analyze whether between‐cohort differences in demographic‐clinical variables explained between‐cohort differences in hippocampal volume. Age and global brain atrophy were the most important variables in explaining variability in hippocampal volume. These variables were not only important themselves but also in interaction with gender, education, MMSE, and total intracranial volume. AddNeuroMed, ADNI, and AIBL differed from the population‐based cohorts in several demographic‐clinical variables that had a significant effect on hippocampal volume. Variability in hippocampal volume in individuals with normal cognition is high. Differences that previously tended to be related to disease mechanisms could also be partly explained by demographic and clinical factors independent from the disease. Furthermore, cognitively normal individuals especially from ADNI and AIBL are not representative of the general population. These findings may have important implications for future research and clinical trials, translating imaging biomarkers to the general population, and validating current diagnostic criteria for Alzheimer's disease and predementia stages.Keywords
This publication has 47 references indexed in Scilit:
- Course, risk factors, and prognostic factors in elderly primary care patients with mild depression: A two-year observational studyScandinavian Journal of Primary Health Care, 2013
- The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old ageFrontiers in Human Neuroscience, 2013
- Comparison of Imaging Biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of AgingArchives of Neurology, 2012
- Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive declineNeurobiology of Aging, 2010
- Trajectories of brain aging in middle-aged and older adults: Regional and individual differencesNeuroImage, 2010
- The clinical use of structural MRI in Alzheimer diseaseNature Reviews Neurology, 2010
- Relationships between biomarkers in aging and dementiaNeurology, 2009
- Cognitive reserveNeuropsychologia, 2009
- Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controlsNeuroImage, 2009
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983